Predictors of exacerbations in asthma

Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Konstantinos Kostikas, Anastasia Papaporfuriou, Elissavet Konstantellou, Georgios Hillas, Nikolaos Koulouris, Spyridon Papiris, Petros Bakakos, Stelios Loukides

Source: International Congress 2015 – Clinical assessment in asthma and COPD
Session: Clinical assessment in asthma and COPD
Session type: Poster Discussion
Number: 4575
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Konstantinos Kostikas, Anastasia Papaporfuriou, Elissavet Konstantellou, Georgios Hillas, Nikolaos Koulouris, Spyridon Papiris, Petros Bakakos, Stelios Loukides. Predictors of exacerbations in asthma. Eur Respir J 2015; 46: Suppl. 59, 4575

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Factors related with hospitalizations due to asthma exacerbations
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014

Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015

Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Characterization of asthma exacerbations in outpatients – National survey
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Use of β-blockers and the risk of asthma exacerbations
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016


Acute exacerbations of asthma in Barcelona, the recent experience
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013


Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013


Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015


Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014

Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015